Advent Life Sciences Overview
We start and invest in early and mid-stage companies with a first-in-class or best-in-class approach. Our investments are focused on new drug discovery across all modalities, med tech, enabling technologies and vaccines.
Is Advent Life Sciences the right VC for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Advent Life Sciences, along with a list of other relevant VCs, is available on Hopohopo.io.
Advent Life Sciences
Investment focus
Invest in
- Baltics
- Nordics
- Western Europe
- Southern Europe
- Central Eastern Europe
- North America
Customer types
- B2B2C
- Consumers
- Governments
- Large enterprises
- Small and medium enterprises
Product type
- Hardware
- Software
- Software-enabled hardware
Industries / verticals
- BioTech
- HealthTech / MedTech
- Life Science
Investment role
Lead and follow
Stages
Pre-seed, Seed, Series A, Series B or later
First ticket size
£1,000,000 - £10,000,000
Contact information
General Partner
Shahzad Malik
General Partner
Raj Parekh
Venture Partner
Katrine Bosley
Venture Partner
Don Drakeman
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
